ASSET PURCHASE AGREEMENTAsset Purchase Agreement • November 15th, 2010 • Elite Pharmaceuticals Inc /De/ • Pharmaceutical preparations • New Jersey
THIS ASSET PURCHASE AGREEMENT (“Agreement”), dated May 18, 2010 (the “Effective Date”), is between Mikah Pharma LLC, a limited liability company organized under the laws of Delaware (“Seller”), and Elite Pharmaceuticals, Inc., a publicly traded company organized under the laws of the State of Delaware (“Buyer”).
PURCHASE AGREEMENT between ELITE PHARMACEUTICALS, INC. and EPIC PHARMA, LLC Dated as of September 10, 2010Purchase Agreement • November 15th, 2010 • Elite Pharmaceuticals Inc /De/ • Pharmaceutical preparations • New York
This PURCHASE AGREEMENT (the “Agreement”) is entered into as of September 10, 2010, by and between ELITE PHARMACEUTICALS, INC. and ELITE LABORATORIES, INC. (a subsidiary of Elite Pharmaceuticals, Inc.), a Delaware corporations with offices at 165 Ludlow Avenue, Northvale, New Jersey 07430 (“Buyer”) and EPIC PHARMA, LLC, a Delaware limited liability corporation with offices at 227-15 N. Conduit Ave., Laurelton, New York 11413 (“Seller”). Seller and Buyer are sometimes hereafter referred to individually as a “Party” and collectively as the “Parties”.
LICENSE AGREEMENTLicense Agreement • November 15th, 2010 • Elite Pharmaceuticals Inc /De/ • Pharmaceutical preparations • Illinois
This License Agreement (“Agreement”) is entered into as of the 10th day of September, 2010 by and between PRECISION DOSE, INC., an Illinois corporation (“PRECISION DOSE”), and ELITE PHARMACEUTICALS, INC. and ELITE LABORATORIES, INC. (a subsidiary of Elite Pharmaceuticals, Inc.), both Delaware corporations (collectively, “ELITE”).
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • November 15th, 2010 • Elite Pharmaceuticals Inc /De/ • Pharmaceutical preparations • New Jersey
THIS ASSET PURCHASE AGREEMENT (“Agreement”), dated August 27, 2010 (the “Effective Date”), is between Mikah Pharma LLC, a limited liability company organized under the laws of Delaware (“Seller”), and Elite Pharmaceuticals, Inc., a publicly traded company organized under the laws of the State of Delaware (“Buyer”).
MASTER DEVELOPMENT AND LICENSE AGREEMENT FOR {***} BETWEEN ELITE PHARMACEUTICALS, INC. AND MIKAH PHARMA, LLCDevelopment and License Agreement • November 15th, 2010 • Elite Pharmaceuticals Inc /De/ • Pharmaceutical preparations • New Jersey
This DEVELOPMENT AND LICENSE AGREEMENT (the “Agreement”), dated August 27, 2010 (the “Effective Date”) between Elite Pharmaceuticals, Inc.and Elite Laboratories, Inc. (a subsidiary of Elite Pharmaceuticals, Inc.), both corporations organized under the laws of the State of Delaware, with offices at 165 Ludlow Avenue, Northvale, New Jersey (“Elite”), and Mikah Pharma, LLC, a Delaware limited liability company with its offices at 20 Kilmer Drive, Hillsborough, New Jersey 08844 (“Mikah”);
MANUFACTURING AND SUPPLY AGREEMENTManufacturing Agreement • November 15th, 2010 • Elite Pharmaceuticals Inc /De/ • Pharmaceutical preparations • Illinois
This Manufacturing and Supply Agreement (the "Agreement") is entered into as of the 10th day of September, 2010 (the "Effective Date"), by and between Precision Dose, Inc., an Illinois corporation ("PRECISION DOSE"), and Elite Pharmaceuticals, Inc. and Elite Laboratories, Inc. (a subsidiary of Elite Pharmaceuticals, Inc.), both Delaware corporations ("ELITE").
